Actively Recruiting
Acute Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies
Led by University of Sao Paulo · Updated on 2024-12-05
40
Participants Needed
1
Research Sites
322 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Systemic autoimmune myopathies are a heterogeneous group of rheumatic diseases that primarily affect the skeletal muscles. The transcranial direct current stimulation technique has been frequent, for example, in patients with ischemic stroke or for the optimization of muscular performance in athletes. However, to date, there are no studies evaluating this technique in patients with systemic autoimmune myopathies. Therefore, the main objective of the present prospective, randomized, double-blind, placebo-controlled study is to evaluate the safety and efficacy of the application of acute transcranial current stimulation session in patients with systemic autoimmune myopathies.
CONDITIONS
Official Title
Acute Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Meet classification criteria of EULAR/ACR 2017
- Meet classification criteria of Connors et al.
- Have objective muscle weakness in limbs
You will not qualify if you...
- Have cancer (neoplasia)
- Use a heart pacemaker
- Have visceral metallic clips
- Have infections such as HIV, HTLV-1, or Hepatitis
- Are pregnant
- Have a history of seizures or epilepsy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Samuel K Shinjo
São Paulo, Brazil, 01246903
Actively Recruiting
Research Team
S
Samuel K Shinjo
CONTACT
S
Sao Paulo University
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here